Table 2.
Immune protection of live vaccine with fructose in mice.
| group | Immunogen | Total mice | Survive No | ADR(%) | RPS1 (%) | RPS2 (%) |
|---|---|---|---|---|---|---|
| 1 | Live vaccine | 30 | 15 | 50.0% | 50.0% | |
| 2 | Live vaccine with 0.18mg Fructose | 30 | 17 | 43.3% | 56.7% | 13.4% |
| 3 | Live vaccine with 1.8mg Fructose | 30 | 23 | 23.3% | 76.7%* | 53.4% * |
| 4 | PBS | 20 | 0 | 100.0% | ||
| 5 | 1.8mg Fructose | 20 | 0 | 100.0% |
All the treatment was same volume (0.1mL). Survived, the number of mice survived in the experiment. ADR, accumulating death rates; RPS, relative percent survival. RPS was calculated as RPS1 = 1 - (% mortality of Fructose and/or bacteria treated group/% mortality of control group) × 100. RPS2 = 1 - (% mortality of Fructose and bacteria treated group/% mortality of bacteria treated group) × 100. The experiments are repeated twice. * P < 0.05.